C N Baker

3.2k total citations
66 papers, 2.5k citations indexed

About

C N Baker is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, C N Baker has authored 66 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 23 papers in Epidemiology and 17 papers in Pharmacology. Recurrent topics in C N Baker's work include Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). C N Baker is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (21 papers), Bacterial Identification and Susceptibility Testing (17 papers) and Antibiotics Pharmacokinetics and Efficacy (17 papers). C N Baker collaborates with scholars based in United States, Uganda and Taiwan. C N Baker's co-authors include Clyde Thornsberry, Fred C. Tenover, C Thornsberry, D G Hollis, Robert E. Weaver, S. Stocker, David H. Culver, Shailendra N. Banerjee, Ronald N. Jones and Linda A. Kirven and has published in prestigious journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

C N Baker

65 papers receiving 2.2k citations

Peers

Countries citing papers authored by C N Baker

Since Specialization

Citations

This map shows the geographic impact of C N Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C N Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C N Baker more than expected).

Fields of papers citing papers by C N Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C N Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C N Baker. The network helps show where C N Baker may publish in the future.

Co-authorship network of co-authors of C N Baker

This figure shows the co-authorship network connecting the top 25 collaborators of C N Baker. A scholar is included among the top collaborators of C N Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C N Baker. C N Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Simplified Method for Testing Bordetella pertussis for Resistance to Erythromycin and Other Antimicrobial Agents 2000 ·Journal of Clinical Microbiology ·Bertha C. Hill, C N Baker, Fred C. Tenover	25
2	Development of provisional disc diffusion breakpoints for testing quinupristin/dalfopristin 1997 ·Journal of Antimicrobial Chemotherapy ·Fred C. Tenover, C N Baker	9
3	Phenotypic characteristics, fatty acid composition, and isoprenoid quinone content of CDC group IIg bacteria 1995 ·Journal of Clinical Microbiology ·D G Hollis, Maryam Daneshvar, C W Moss, C N Baker	6
4	Optimizing testing of methicillin-resistant Staphylococcus species 1994 ·Diagnostic Microbiology and Infectious Disease ·C N Baker, Ming Huang, Fred C. Tenover	23
5	Prevalence of Neisseria meningitidis Relatively Resistant to Penicillin in the United States, 1991 1994 ·The Journal of Infectious Diseases ·Lisa A. Jackson, Fred C. Tenover, C N Baker, Brian D. Plikaytis, M. W. Reeves, S. Stocker, Robert E. Weaver, Jay D. Wenger, (unknown)	55
6	Two percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methods 1993 ·Journal of Clinical Microbiology ·Ming Huang, (unknown), C N Baker, Shailendra N. Banerjee, Fred C. Tenover	59
7	Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters 1993 ·Journal of Clinical Microbiology ·A L Barry, Peter Fuchs, S D Allen, J H Jorgensen, Fred C. Tenover, Patrick R. Murray, Dwight J. Hardy, C N Baker	4
8	The E-Test and Campylobacter jejuni 1992 ·Diagnostic Microbiology and Infectious Disease ·C N Baker	41
9	Campylobacter butzleri sp. nov. isolated from humans and animals with diarrheal illness 1991 ·Journal of Clinical Microbiology ·Julia A. Kiehlbauch, D J Brenner, M A Nicholson, C N Baker, C M Patton, A G Steigerwalt, I K Wachsmuth	137
10	Meningococcal Disease in the United States--1986 1991 ·The Journal of Infectious Diseases ·Robert W. Pinner, (unknown), W F Bibb, C N Baker, Robert E. Weaver, Susan B. Hunter, Stephen H. Waterman, L F Mocca, Carl E. Frasch, Claire V. Broome, (unknown)	61
11	Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States 1989 ·Journal of Clinical Microbiology ·C M Patton, Nathan Shaffer, Paul Edmonds, Timothy J. Barrett, M A Lambert, C N Baker, D. Perlman, D J Brenner	78
12	Methods for determining susceptibility of fastidious and unusual pathogens to selected antimicrobial agents 1988 ·Diagnostic Microbiology and Infectious Disease ·C Thornsberry, Jana M. Swenson, C N Baker, Linda K. McDougal, Sheila A. Stocker, Bertha C. Hill	13
13	Relationship between in vitro susceptibility test results for chloramphenicol and production of chloramphenicol acetyltransferase by Haemophilus influenzae, Streptococcus pneumoniae, and Aerococcus species 1988 ·Journal of Clinical Microbiology ·(unknown), C N Baker, Clyde Thornsberry	14
14	autoSCAN-4 system for identification of gram-negative bacilli 1985 ·Journal of Clinical Microbiology ·D L Rhoden, Peter B. Smith, C N Baker, Barbara Schable	11
15	Inoculum standardization in antimicrobial susceptibility testing: evaluation of overnight agar cultures and the Rapid Inoculum Standardization System 1983 ·Journal of Clinical Microbiology ·C N Baker, Clyde Thornsberry, R W Hawkinson	56
16	Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin 1980 ·Antimicrobial Agents and Chemotherapy ·Clyde Thornsberry, A L Barry, Ronald N. Jones, C N Baker, Robert E. Badal, R R Packer	13
17	Piperacillin susceptibility tests by the single-disk agar diffusion technique 1979 ·Antimicrobial Agents and Chemotherapy ·A L Barry, C Thornsberry, Robert E. Badal, C N Baker, Ronald N. Jones, E. Gerlach	16
18	Antistreptolysin O Test: Comparison of Micro and Macro Technics 1970 ·American Journal of Clinical Pathology ·George C. Klein, Elmer C. Hall, C N Baker, (unknown)	4
19	Micro Test for Streptococcal Anti-deoxyribonuclease B 1969 ·Applied Microbiology ·George C. Klein, C N Baker, (unknown), Max D. Moody	4
20	Micro Test for Streptococcal Anti-deoxyribonuclease B 1969 ·Applied Microbiology ·George C. Klein, C N Baker, (unknown), Max D. Moody	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact